TRAPPC9
Basic information
Region (hg38): 8:139727725-140458579
Links
Phenotypes
GenCC
Source:
- intellectual disability, autosomal recessive 13 (Definitive), mode of inheritance: AR
- autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
- intellectual disability-obesity-brain malformations-facial dysmorphism syndrome (Supportive), mode of inheritance: AR
- intellectual disability, autosomal recessive 13 (Moderate), mode of inheritance: AR
- intellectual disability, autosomal recessive 13 (Strong), mode of inheritance: AR
- intellectual disability-obesity-brain malformations-facial dysmorphism syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual developmental disorder, autosomal recessive 13 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Endocrine; Neurologic | 17120046; 20004765; 20004763; 20004764; 21629298; 22549410; 22989526 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (25 variants)
- Intellectual disability, autosomal recessive 13 (15 variants)
- Abnormality of the nervous system (2 variants)
- Inborn genetic diseases (2 variants)
- Autism spectrum disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRAPPC9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 186 | 200 | ||||
missense | 269 | 277 | ||||
nonsense | 14 | 21 | ||||
start loss | 0 | |||||
frameshift | 16 | 23 | ||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 10 | 13 | ||||
splice region | 11 | 20 | 2 | 33 | ||
non coding | 34 | 128 | 51 | 219 | ||
Total | 37 | 24 | 312 | 321 | 60 |
Highest pathogenic variant AF is 0.0000263
Variants in TRAPPC9
This is a list of pathogenic ClinVar variants found in the TRAPPC9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-139730384-A-G | Intellectual Disability, Recessive | Uncertain significance (Jun 14, 2016) | ||
8-139730485-C-T | Intellectual Disability, Recessive | Uncertain significance (Jun 14, 2016) | ||
8-139730529-C-T | Intellectual Disability, Recessive | Conflicting classifications of pathogenicity (Jul 01, 2023) | ||
8-139730686-G-A | Intellectual Disability, Recessive | Likely benign (Jun 14, 2016) | ||
8-139730730-G-A | Intellectual Disability, Recessive | Uncertain significance (Jun 14, 2016) | ||
8-139730776-T-G | Intellectual Disability, Recessive | Uncertain significance (Jun 14, 2016) | ||
8-139730880-C-T | Intellectual Disability, Recessive | Uncertain significance (Jun 14, 2016) | ||
8-139730896-C-G | Likely benign (Jul 15, 2018) | |||
8-139730957-G-A | Intellectual Disability, Recessive | Benign (Jul 09, 2018) | ||
8-139730981-C-G | Intellectual Disability, Recessive | Uncertain significance (Jun 14, 2016) | ||
8-139730996-G-C | Intellectual Disability, Recessive | Uncertain significance (Jun 14, 2016) | ||
8-139731065-G-T | not specified | Uncertain significance (May 03, 2024) | ||
8-139731070-C-T | Inborn genetic diseases | Likely benign (Jan 22, 2024) | ||
8-139731071-G-A | Uncertain significance (Oct 07, 2021) | |||
8-139731072-C-G | Uncertain significance (Mar 26, 2022) | |||
8-139731087-C-T | not specified • Inborn genetic diseases • TRAPPC9-related disorder | Conflicting classifications of pathogenicity (Jan 25, 2024) | ||
8-139731088-G-A | Inborn genetic diseases | Likely benign (Oct 03, 2023) | ||
8-139731094-A-C | Intellectual Disability, Recessive • not specified • Intellectual disability • Inborn genetic diseases | Conflicting classifications of pathogenicity (Jan 22, 2024) | ||
8-139731097-G-T | Intellectual Disability, Recessive • not specified • Inborn genetic diseases • TRAPPC9-related disorder | Conflicting classifications of pathogenicity (Jan 20, 2024) | ||
8-139731103-G-T | Uncertain significance (Mar 18, 2022) | |||
8-139731108-A-T | Uncertain significance (Nov 15, 2021) | |||
8-139731118-T-G | not specified • Inborn genetic diseases | Benign/Likely benign (Jan 24, 2024) | ||
8-139731122-A-G | Inborn genetic diseases | Uncertain significance (Mar 07, 2024) | ||
8-139731144-C-T | not specified • Intellectual disability, autosomal recessive 13 | Uncertain significance (Jul 06, 2021) | ||
8-139731145-G-A | Likely benign (Sep 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRAPPC9 | protein_coding | protein_coding | ENST00000389328 | 23 | 726093 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.29e-14 | 1.00 | 125646 | 0 | 102 | 125748 | 0.000406 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.48 | 626 | 739 | 0.847 | 0.0000489 | 8073 |
Missense in Polyphen | 331 | 398.34 | 0.83096 | 4318 | ||
Synonymous | -1.64 | 353 | 316 | 1.12 | 0.0000231 | 2503 |
Loss of Function | 3.23 | 32 | 58.7 | 0.545 | 0.00000318 | 650 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00144 | 0.00142 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.000276 | 0.000272 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000382 | 0.000378 |
Middle Eastern | 0.000276 | 0.000272 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000672 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as an activator of NF-kappa-B through increased phosphorylation of the IKK complex. May function in neuronal cells differentiation. May play a role in vesicular transport from endoplasmic reticulum to Golgi. {ECO:0000269|PubMed:15951441}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Rab regulation of trafficking;RAB GEFs exchange GTP for GDP on RABs;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport
(Consensus)
Intolerance Scores
- loftool
- 0.0201
- rvis_EVS
- -1.65
- rvis_percentile_EVS
- 2.77
Haploinsufficiency Scores
- pHI
- 0.167
- hipred
- Y
- hipred_score
- 0.526
- ghis
- 0.610
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.380
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trappc9
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; muscle phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype; immune system phenotype; skeleton phenotype; renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype;
Gene ontology
- Biological process
- cerebral cortex development;neuron differentiation;COPII vesicle coating;positive regulation of NF-kappaB transcription factor activity
- Cellular component
- Golgi membrane;endoplasmic reticulum;trans-Golgi network;cytosol;TRAPP complex
- Molecular function
- protein binding;Rab guanyl-nucleotide exchange factor activity